This document has been developed in partnership between the All Wales Medicines Procurement Pharmacist representing the Welsh Medicines Procurement and Logistics Advisory Group (WMPLAG) and ABPI Wales.
The Welsh Medicines Procurement and Logistics Advisory Group report to the All Wales Chief Pharmacist Group and have a broad membership of finance, procurement, quality assurance (QA), clinical and chief pharmacist representation from across NHS Wales.
This document is intended to specifically inform ABPI members, describing some of the terminology, processes and procedures they may choose to consider when planning market access for their medicines in NHS Wales, especially when those plans include alternative commercial or supply chain arrangements.